Verny C, de Gennes C, Sébastien P, Lê Thi H D, Chapelon C, Piette J C, Chomette G, Godeau P
Service de Médecine interne, Hôpital de La Pitié, Paris.
Presse Med. 1992;21(17):800-4.
Cardiac complications are exceptional in long-term chloroquine therapy; congestive heart failure and restrictive cardiomyopathy may develop, but disorders of conduction are more frequent. The characteristics of these disorders emerge from 12 cases in the literature and from 2 personal cases. The usual disorder is fascicular block which may become a complete, syncopal, atrioventricular block, as in one of our 2 patients. The time elapsed between the beginning of treatment and the occurrence of these disorders (2 to 30 years) and the total dose of chloroquine received (100 to 2,500 g) are extremely variable. Retinopathy or neuromyopathy is present in 64 and 35 percent of the cases respectively. The diagnosis is confirmed by endomyocardial biopsy with electron microscopic study which shows vaculoar myopathy with numerous large secondary lysosomes containing a dense material of lamellar structure (myelinic figures, curvilinear bodies). Regression of heart conduction disorders after withdrawal of chloroquine seems to be inconstant and incomplete. The rare occurrence of this complication raises the question of genetic predisposition. We believe that chloroquine therapy should be contra-indicated in patients with a history of conduction disorders and that a 6-monthly electrocardiographic control of these patients would be justified.
心脏并发症在长期氯喹治疗中较为罕见;可能会出现充血性心力衰竭和限制性心肌病,但传导障碍更为常见。这些障碍的特征源于文献中的12例病例以及2例个人病例。常见的障碍是束支传导阻滞,可能会发展为完全性、晕厥性房室传导阻滞,就像我们的2例患者中的1例那样。从开始治疗到出现这些障碍的时间(2至30年)以及氯喹的总摄入量(100至2500克)差异极大。视网膜病变或神经肌肉病变分别出现在64%和35%的病例中。通过心内膜活检及电子显微镜研究确诊,结果显示有空泡性肌病,有许多大型次级溶酶体,其中含有层状结构的致密物质(髓鞘样结构、曲线体)。停用氯喹后心脏传导障碍的消退似乎并不稳定且不完全。这种并发症的罕见发生引发了遗传易感性的问题。我们认为,有传导障碍病史的患者应禁用氯喹治疗,并且对这些患者每6个月进行一次心电图检查是合理的。